CNBC January 11, 2023
Spencer Kimball

Key Points

– The Health and Human Services Department will select 10 Medicare Part D drugs this year for price negotiations with manufacturers.

– The federal government for the first time has the power to negotiate Medicare drug prices due to the Inflation Reduction Act.

– The actual negotiations begin in 2024 and the prices will go into effect in 2025.

The Health and Human Services Department plans to publish in September a list of 10 drugs covered by Medicare that it will target for price negotiations, the first phase in a long awaited effort to cut costs for seniors.

HHS officials, in a call with reporters on Wednesday, laid out the federal government’s road map for negotiating drug prices...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Govt Agencies, HHS, Insurance, Medicare, Pharma, Pharma / Biotech
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Prior authorizations, pharmacy transparency, vertical integration all part of the Medicare 2026 rule
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article